Statin use in very elderly individuals, 1999-2012

JAMA Internal Medicine

Volumn 175, Issue 10, 2015, Pages 1715-1716

  Johansen, Michael E ^a   Green, Lee A ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

AGED; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DRUG INFORMATION; DRUG USE; HEALTH CARE QUALITY; HEALTH CARE SURVEY; HUMAN; INSTITUTIONAL REVIEW; INVESTIGATIVE PROCEDURES; ISCHEMIC HEART DISEASE; LETTER; LIVER DISEASE; PERIPHERAL VASCULAR DISEASE; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SELF REPORT; UNITED STATES; AGE; CARDIOVASCULAR DISEASES; DRUG UTILIZATION; FEMALE; MALE; PROCEDURES; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY;

AGE FACTORS; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DRUG UTILIZATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PRIMARY PREVENTION; RISK ADJUSTMENT; SECONDARY PREVENTION; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84943532315     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.4302     Document Type: Letter

References (6)

1. Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA. 2014;312(11): 1136-1144.
2. Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? a review of observational studies and RCTs on cholesterol and mortality in 80+ year olds. Age Ageing. 2010;39(6):674-680.
3. Gu Q, Paulose-Ram R, Burt VL, Kit BK. Prescription Cholesterol-Lowering Medication Use in Adults Aged 40 and Over: United States, 2003-2012: NCHS Data Brief No 177. Hyattsville, MD: National Center for Health Statistics; 2014.
4. Medical Expenditure Panel Survey: 2012 Consolidated Data File. http://meps.ahrq.gov/mepsweb/data-stats/download-data/pufs/h155/h155doc.pdf. Accessed May 30, 2015.
5. Hill SC, Zuvekas SH, Zodet MW. Implications of the accuracy of MEPS prescription drug data for health services research. Inquiry. 2011;48(3):242-259.
6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25): 3143-3421.